Atlas Trials

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Clinical trial NCT00156273 · COMPLETED

Trial details

NCT number
NCT00156273
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2005-04-01
Primary completion
2008-10-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.